↓ Skip to main content

Dove Medical Press

Dextromethorphan and memantine after ketamine analgesia: a randomized control trial

Overview of attention for article published in Drug Design, Development and Therapy, August 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
2 X users
facebook
1 Facebook page
video
1 YouTube creator

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
99 Mendeley
Title
Dextromethorphan and memantine after ketamine analgesia: a randomized control trial
Published in
Drug Design, Development and Therapy, August 2019
DOI 10.2147/dddt.s207350
Pubmed ID
Authors

Elodie Martin, Marc Sorel, Véronique Morel, Fabienne Marcaillou, Pascale Picard, Noémie Delage, Florence Tiberghien, Marie-Christine Crosmary, Mitra Najjar, Renato Colamarino, Christelle Créach, Béatrice Lietar, Géraldine Brumauld de Montgazon, Anne Margot-Duclot, Marie-Anne Loriot, Céline Narjoz, Céline Lambert, Bruno Pereira, Gisèle Pickering

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 99 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 17%
Other 10 10%
Student > Master 9 9%
Researcher 8 8%
Student > Ph. D. Student 4 4%
Other 13 13%
Unknown 38 38%
Readers by discipline Count As %
Medicine and Dentistry 15 15%
Nursing and Health Professions 12 12%
Psychology 8 8%
Neuroscience 7 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 7%
Other 10 10%
Unknown 40 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 May 2022.
All research outputs
#15,230,090
of 25,462,162 outputs
Outputs from Drug Design, Development and Therapy
#824
of 2,272 outputs
Outputs of similar age
#187,319
of 359,695 outputs
Outputs of similar age from Drug Design, Development and Therapy
#15
of 46 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,272 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,695 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.